| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/14/1995 | US5389381 Administering superoxide dismutase bound to low diol polyoxyethylene glycol with buffers and protective cyclodextrins |
| 02/14/1995 | US5389380 Sustained release pharmaceutical preparation and process for preparing the same |
| 02/14/1995 | US5389377 Solid care therapeutic compositions and methods for making same |
| 02/14/1995 | US5389373 Preparation of oil-in-water emulsions of drugs |
| 02/14/1995 | US5389372 Addition of sucrose extends shelf life |
| 02/14/1995 | US5389366 Neocarzinostatin bound to maleic acid-styrene copolymer, fatty acid glyceride, amphiphilic agent |
| 02/14/1995 | CA2129763A1 Insulin formulation |
| 02/14/1995 | CA1334382C Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties |
| 02/14/1995 | CA1334379C Method for preparing a solid sustained release form of a functionally active composition |
| 02/14/1995 | CA1334321C Liquid based composition comprising a gelling polysaccharide capable of forming a reversible gel and a method of preparing such composition |
| 02/12/1995 | CA2128641A1 Stabilized solutions of platinum (ii) antitumor agents |
| 02/09/1995 | WO1995004068A1 Oligomers for modulating human immunodeficiency virus |
| 02/09/1995 | WO1995004030A1 Therapeutic compound - fatty acid conjugates |
| 02/09/1995 | WO1995003838A1 Psoriasis treatment |
| 02/09/1995 | WO1995003831A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | WO1995003830A2 Prodrugs of farnesyl transferase inhibitors for adept or vdept |
| 02/09/1995 | WO1995003829A1 A method and pharmaceutical compositions for drug targeting |
| 02/09/1995 | WO1995003828A1 Single-chain immunotoxin compositions and methods for preventing secondary cataracts |
| 02/09/1995 | WO1995003823A1 Therapeutic compositions comprising a polypeptide |
| 02/09/1995 | WO1995003818A1 Powder for nasal administration of peptidic or proteinaceous drug |
| 02/09/1995 | WO1995003805A1 Stabilized formulation |
| 02/09/1995 | WO1995003802A1 Aqueous composition |
| 02/09/1995 | WO1995003791A1 Stabilized pharmaceutical composition containing bupropion |
| 02/09/1995 | WO1995003790A1 Use of cross-linked copolymers of monoethylenically unsaturated carboxylic acids as stabilizers in oil-in-water emulsions |
| 02/09/1995 | WO1995003784A1 Suspensions for delivery of medicament |
| 02/09/1995 | WO1995003781A1 Personal cleansing compositions |
| 02/09/1995 | WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 02/09/1995 | WO1995003775A1 Antifungal nail solution |
| 02/09/1995 | WO1994022437A3 Method for treating amyloidosis |
| 02/09/1995 | CA2168647A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | CA2168543A1 Personal cleansing compositions |
| 02/09/1995 | CA2167818A1 Therapeutic compound - fatty acid conjugates |
| 02/09/1995 | CA2167726A1 The use of crosslinked copolymers of monoethylenically unsaturated carboxylic acids as stabilizer in oil-in-water emulsions |
| 02/09/1995 | CA2167480A1 Improvements relating to prodrugs |
| 02/09/1995 | CA2165299A1 Suspensions for delivery of medicament |
| 02/09/1995 | CA2144729A1 Aqueous composition |
| 02/08/1995 | EP0637591A2 A novel expression vector for phytolacca antiviral protein |
| 02/08/1995 | EP0637463A1 Stable aqueous suspension of liposome |
| 02/08/1995 | EP0637451A1 Preparation of blood coagulation factor XIII without viruses |
| 02/08/1995 | EP0637450A2 Composition for revitalizing scar tissue |
| 02/08/1995 | EP0637447A2 Orally administrable cholesterol lowering agent |
| 02/08/1995 | EP0637321A1 Use of copolymers of carboxylic acids and long-chained compounds with isolated multiple c-c bonds as thickening or dispersing agents. |
| 02/08/1995 | EP0637248A1 Pharmaceutical composition containing cyclosporin derivative |
| 02/08/1995 | CN1098288A Pharmaceutical composition |
| 02/08/1995 | CN1098286A PH-triggered osmotic bursting delivery devices |
| 02/07/1995 | US5387672 Hemoglobin intramolecularly cross-linked withlong chain divalent reagents |
| 02/07/1995 | US5387611 Use of butylurea, nonoxynol-9 and benzalkonium chloride as anti-bacterial, anti-viral contraceptive agents |
| 02/07/1995 | US5387578 Releasing drugs from bioactive agents in order to improve the therapeutic efficacy and reduce their toxic effects |
| 02/07/1995 | US5387431 Saccharide-based matrix |
| 02/07/1995 | US5387420 Storage stability |
| 02/07/1995 | CA2030911C Pharmaceutical preparations |
| 02/07/1995 | CA1334290C Plant gum material and use thereof in food products |
| 02/07/1995 | CA1334280C Aqueous gels containing topical medicaments |
| 02/07/1995 | CA1334274C Surfactant compositions of phosphoric esters of poly (phenyl-1-ethyl) polyoxyalkylenes phenols, a process for their preparation and use in the preparation of aqueous dispersions of active substances |
| 02/05/1995 | CA2103938A1 Method and composition for revitalizing scar tissue |
| 02/03/1995 | CA2129099A1 Pharmaceutical compositions having good dissolution properties |
| 02/02/1995 | WO1995003357A1 Biodegradable particles |
| 02/02/1995 | WO1995003356A1 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 02/02/1995 | WO1995003352A1 Hydroxysilyl-terminated polyoxyethylene compound, quaternary-salt-terminated block copolymer, and percutaneous absorption promoter |
| 02/02/1995 | WO1995003315A2 Saccharides, their synthesis and use |
| 02/02/1995 | WO1995003272A1 Novel organic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said products |
| 02/02/1995 | WO1995003064A1 Polymeric carriers for non-covalent drug conjugation |
| 02/02/1995 | WO1995003050A2 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | WO1995003034A1 Stabilization of aerosolized proteins |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | WO1994029316A3 Texaphyrin metal complex mediated ester hydrolysis |
| 02/02/1995 | WO1994028780A3 Methods of preparing gas and gaseous precursor-filled microspheres |
| 02/02/1995 | WO1994024984A3 Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto |
| 02/02/1995 | DE4400770C1 Plaster containing an active substance for delivery of oestradiol with at least one penetration enhancer, method of producing it and its use |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2167920A1 Nonoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 02/02/1995 | CA2167574A1 Polymeric carriers for non-covalent drug conjugation |
| 02/02/1995 | CA2167538A1 Stabilization of aerosolized proteins |
| 02/01/1995 | EP0636634A1 Derivatives of gamma-cyclodextrin |
| 02/01/1995 | EP0636632A2 Non-reducing oligosaccharides and their production and use |
| 02/01/1995 | EP0636631A1 Platinum complex and antineoplastic agent |
| 02/01/1995 | EP0636378A1 Absorbable composite materials for use in the treatment of periodontal disease |
| 02/01/1995 | EP0636374A2 A spermicidal anti-viral lubricant composition |
| 02/01/1995 | EP0636370A1 Sustained release compositions containing morphine |
| 02/01/1995 | EP0636362A2 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| 02/01/1995 | EP0636315A1 Slow-releasing compositions |
| 02/01/1995 | EP0636033A1 Process for producing active agent complexes |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | EP0636023A1 Aminoguanidine spray drying process |
| 02/01/1995 | EP0636020A1 A pharmaceutical carrier system containing defined lipids |
| 02/01/1995 | EP0519950B1 Pharmaceutical composition |
| 02/01/1995 | EP0495776B1 Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents |
| 02/01/1995 | CN1098009A Extrudable composition for topical or transdermal drug delivery |
| 02/01/1995 | CN1097984A Methods for administering biological agents and microparticle compositions useful in these and other methods |
| 02/01/1995 | CN1097980A 壳聚糖明胶海绵 Chitosan gelatin sponge |
| 01/31/1995 | US5386023 Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
| 01/31/1995 | US5386014 Reducing and deoxygenating bovine hemoglobin; conjugation to activated polyalkylene oxide in presence of chloride anions |
| 01/31/1995 | US5385938 application of mixtures containing hydroxyacetic acid(or its salts) to skin |
| 01/31/1995 | US5385907 Ointments containing FK-506 or derivatives thereof |
| 01/31/1995 | US5385890 Improved solubility; mixture with polyoxyethylene glycol sorbital alkyl ester |
| 01/31/1995 | US5385822 Methods for detection and quantification of cell subsets within subpopulations of a mixed cell population |
| 01/31/1995 | US5385739 Stable compositions of gastroprotected omerprazole microgranules and process for the production thereof |